HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
1.700
+0.010 (0.59%)
Oct 2, 2026, 11:17 AM EDT - Market open
HCW Biologics Employees
HCW Biologics had 35 employees as of December 31, 2025. The number of employees decreased by 1 or -2.78% compared to the previous year.
Employees
35
Change (1Y)
-1
Growth (1Y)
-2.78%
Revenue / Employee
$192,034
Profits / Employee
-$611,719
Market Cap
3.12M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 35 | -1 | -2.78% |
| Dec 31, 2024 | 36 | -9 | -20.00% |
| Dec 31, 2023 | 45 | 1 | 2.27% |
| Dec 31, 2022 | 44 | 0 | - |
| Dec 31, 2021 | 44 | 4 | 10.00% |
| Mar 31, 2021 | 40 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aptevo Therapeutics | 33 |
| GeoVax Labs | 19 |
| VivoSim Labs | 15 |
| BioRestorative Therapies | 14 |
| Revelation Biosciences | 9 |
| Jupiter Neurosciences | 5 |
| Cadrenal Therapeutics | 5 |
| Mustang Bio | 4 |
HCWB News
- 1 day ago - HCW Biologics Proxy statement: Proxy filing - Filings
- 8 days ago - HCW Biologics prices 903,614 units at $1.6599 in private placement - TheFly
- 8 days ago - HCW Biologics Announces Pricing of $1.5 Million Private Placement - GlobeNewsWire
- 23 days ago - HCW Biologics Proxy statement: Proxy filing - Filings
- 24 days ago - HCW Biologics enters exclusive HCW11-006 distribution pact with Akron Biotech - TheFly
- 24 days ago - HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells - GlobeNewsWire
- 24 days ago - HCW Biologics Proxy statement: Proxy filing - Filings
- 4 weeks ago - HCW Biologics receives patent allowance for alopecia areata drug - TheFly